$29.19
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Integra Lifesciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Integra Lifesciences using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IART | Integra Lifesciences | $0.71 | $0.62 | — | — | $381.30M | $413.15M | — | — | 07/24/2024 | Get Alert |
IART | Integra Lifesciences | $0.74 | $0.55 | $0.55 | 0.00% | $380.85M | $361.96M | $368.87M | 1.91% | 05/06/2024 | Get Alert |
IART | Integra Lifesciences | $0.94 | $0.90 | $0.89 | -1.11% | $398.02M | $399.34M | $397.04M | -0.58% | 02/28/2024 | Get Alert |
IART | Integra Lifesciences | $0.86 | $0.78 | $0.76 | -2.56% | $385.19M | $387.12M | $382.42M | -1.21% | 10/25/2023 | Get Alert |
IART | Integra Lifesciences | $0.82 | $0.57 | $0.71 | — | $397.81M | $374.07M | $381.30M | 1.93% | 07/26/2023 | Get Alert |
IART | Integra Lifesciences | $0.74 | $0.74 | $0.74 | 0.00% | $376.64M | $373.21M | $380.85M | 2.05% | 04/26/2023 | Get Alert |
IART | Integra Lifesciences | $0.84 | $0.90 | $0.94 | 4.44% | $405.52M | $397.95M | $398.02M | 0.02% | 02/22/2023 | Get Alert |
IART | Integra Lifesciences | $0.86 | $0.73 | $0.86 | 17.81% | $386.86M | $381.24M | $385.19M | 1.04% | 10/26/2022 | Get Alert |
IART | Integra Lifesciences | $0.79 | $0.80 | $0.82 | 2.50% | $389.99M | $395.27M | $397.81M | 0.64% | 07/27/2022 | Get Alert |
IART | Integra Lifesciences | $0.69 | $0.68 | $0.74 | 8.82% | $360.07M | $362.04M | $376.64M | 4.03% | 04/27/2022 | Get Alert |
IART | Integra Lifesciences | $0.84 | $0.83 | $0.84 | 1.20% | $388.65M | $403.40M | $405.52M | 0.53% | 02/23/2022 | Get Alert |
IART | Integra Lifesciences | $0.80 | $0.72 | $0.86 | 19.44% | $370.23M | $384.58M | $386.86M | 0.59% | 11/02/2021 | Get Alert |
IART | Integra Lifesciences | $0.33 | $0.66 | $0.79 | 19.70% | $258.67M | $376.01M | $389.99M | 3.72% | 07/28/2021 | Get Alert |
IART | Integra Lifesciences | $0.48 | $0.57 | $0.69 | 21.05% | $354.32M | $349.81M | $360.07M | 2.93% | 04/28/2021 | Get Alert |
IART | Integra Lifesciences | $0.68 | $0.73 | $0.84 | 15.07% | $395.13M | $388.58M | $388.65M | 0.02% | 02/18/2021 | Get Alert |
IART | Integra Lifesciences | $0.68 | $0.53 | $0.80 | 50.94% | $379.10M | $347.98M | $370.23M | 6.39% | 10/28/2020 | Get Alert |
IART | Integra Lifesciences | $0.73 | $0.10 | $0.33 | 230.00% | $383.64M | $242.80M | $258.67M | 6.53% | 08/10/2020 | Get Alert |
IART | Integra Lifesciences | $0.65 | $0.64 | $0.48 | -25.00% | $359.69M | $363.24M | $354.32M | -2.45% | 05/07/2020 | Get Alert |
IART | Integra Lifesciences | $0.65 | $0.67 | $0.68 | 1.49% | $383.31M | $397.50M | $395.13M | -0.60% | 02/19/2020 | Get Alert |
IART | Integra Lifesciences | $0.59 | $0.65 | $0.68 | 4.62% | $365.85M | $376.69M | $379.10M | 0.64% | 10/24/2019 | Get Alert |
IART | Integra Lifesciences | $0.60 | $0.66 | $0.73 | 10.61% | $366.19M | $373.29M | $383.64M | 2.77% | 07/24/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-06 | $0.55 | $0.55 | 0.00 % |
Dec 2023 | 2024-02-28 | $0.89 | $0.90 | -1.11 % |
Sep 2023 | 2023-10-25 | $0.76 | $0.78 | -2.56 % |
Mar 2023 | 2023-04-26 | $0.74 | $0.74 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-06 | $368.87M | $361.96M | 1.91 % |
Dec 2023 | 2024-02-28 | $397.04M | $399.34M | -0.58 % |
Sep 2023 | 2023-10-25 | $382.42M | $387.12M | -1.21 % |
Jun 2023 | 2023-07-26 | $381.30M | $374.07M | 1.93 % |
Integra Lifesciences (IART) is scheduled to report earnings on July 24, 2024. The last reported earnings were for reported on May 6, 2024 for Q1.
The Actual EPS was $0.55, which hit the estimate of $0.55.
The Actual Revenue was $368.9M, which beat the estimate of $362M.
Browse earnings estimates, EPS, and revenue on all stocks.